Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 3/2012

01-03-2012 | Letter to the Editors

Anti-NMDA receptor antibodies in a case of MELAS syndrome

Authors: Carsten Finke, Harald Prüss, Michael Scheel, Florian Ostendorf, Lutz Harms, Kathrin Borowski, Klaus-Peter Wandinger, Christoph J. Ploner

Published in: Journal of Neurology | Issue 3/2012

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
Wandinger KP, Saschenbrecker S, Stoecker W et al (2011) Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 231:86–91PubMedCrossRef
2.
Pavlakis SG, Phillips PC, DiMauro S et al (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 16:481–488PubMedCrossRef
3.
Matthews PM, Andermann F, Silver K et al (1993) Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43:2484–2490
4.
Irani SR, Bera K, Waters P et al (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667PubMedCrossRef
5.
Dalmau J, Lancaster E, Martinez-Hernandez E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74PubMedCrossRef
6.
Corman V, Rorive M, Hennen G et al (2001) Clinical case of the month. MELAS syndrome. Revue Médicale De Liège. 56:681–684PubMed
7.
Huang CN, Jee SH, Hwang JJ et al (1998) Autoimmune IDDM in a sporadic MELAS patient with mitochondrial tRNA(Leu(UUR)) mutation. Clin Endocrinol 49:265–270CrossRef
8.
Li HY, Yang WS, Tai TY et al (2003) A diabetic subject with MELAS and antiphospholipid syndrome. Diabetes Care 26:2218–2219PubMedCrossRef
9.
Ohno K, Yamamoto M, Engel AG et al (1996) MELAS- and Kearns-Sayre-type co-mutation with myopathy and autoimmune polyendocrinopathy. Ann Neurol 39:761–766PubMedCrossRef
Metadata
Title
Anti-NMDA receptor antibodies in a case of MELAS syndrome
Authors
Carsten Finke
Harald Prüss
Michael Scheel
Florian Ostendorf
Lutz Harms
Kathrin Borowski
Klaus-Peter Wandinger
Christoph J. Ploner
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 3/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6229-0

Other articles of this Issue 3/2012

Journal of Neurology 3/2012 Go to the issue

ENS Communications

Communications of the European Neurological Society

Letter to the Editors

Acute painful lumbosacral paresthesia after intrathecal rituximab

Letter to the Editors

Increase in number of sporadic inclusion body myositis (sIBM) in Japan

Original Communication

The pattern of cortical atrophy in Parkinson’s disease with mild cognitive impairment according to the timing of cognitive dysfunction

Letter to the Editors

Probing for consciousness after severe brain injury by functional magnetic resonance imaging (fMRI)

Letter to the Editors

Flexion myelopathy: Hirayama’s syndrome